Please Wait

Applying Filters...

Annual Sales of MolPort-001-641-065 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

MolPort-001-641-065

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 20 USDMF, 9 CEP/COS, 5 JDMF, 4 EU WC, 19 NDC API, 1 VMF, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

356 FDF Dossiers, 94 FDA Orange Book, 129 Europe, 27 Canada, 28 Australia, 37 South Africa, 41 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, INJECTABLE;INJECTION - 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 1 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 6 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 25 Kerry, 13 Microlex e.U, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 26 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 34 Direct Compression, 20 Disintegrants & Superdisintegrants, 20 Granulation, 20 Lubricants & Glidants, 18 Co-Processed Excipients, 16 Thickeners and Stabilizers, 15 Film Formers & Plasticizers, 13 Parenteral, 12 Coating Systems & Additives, 11 Taste Masking, 11 Controlled & Modified Release, 10 Solubilizers, 7 Topical, 7 Chewable & Orodispersible Aids, 4 Emulsifying Agents, 3 API Stability Enhancers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 111 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

37 APIs, 40 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 4 JP, 10 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

6 All

01 5Lasix

02 1Salix

List of Suppliers

Product Main Page

01

Brand Name : Lasix

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Main Therapeutic Indication : Cardiovascular

Currency : USD

2014 Revenue in Millions : -4.70%

2013 Revenue in Millions :

Growth (%) :

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

02

Brand Name : Lasix

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Main Therapeutic Indication : Cardiovascular

Currency : USD

2015 Revenue in Millions : 180

2014 Revenue in Millions : 178

Growth (%) : -1%

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

03

Brand Name : Lasix

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 157

2015 Revenue in Millions : 172

Growth (%) : -9

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

04

Brand Name : Lasix

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 170

2016 Revenue in Millions : 184

Growth (%) : -7

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

05

Brand Name : Lasix

CPhI Worldwide, Milan

Contact Supplier

Contact Supplier

Digital Content

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 0

2017 Revenue in Millions : 155

Growth (%) : -100%

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

06

Brand Name : Salix

Boulder Peptide 2024

Not Confirmed

Contact us
to update this info